Philippines To Remake Drug Regulatory Group Along The Lines Of U.S. FDA
This article was originally published in PharmAsia News
Executive Summary
SHANGHAI - Philippines President Gloria Macapagal-Arroyo signed new legislation this month that is aimed at transforming the nation's top drug regulatory group, currently called the Bureau of Food and Drugs, and modeling it after the American FDA